ArticlemedRxiv : the preprint server for health sciences2025
Neurite Degradation Mediates the Effect of Amyloid Deposition on Global Cognition in Asymptomatic Older Adults.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study investigates whether amyloid deposition is associated with neurite degradation in cognitively unimpaired (asymptomatic) older adults, with a focus on brain regions critical for memory and cognition. Using data from the ADNI3 cohort (n = 65; mean age 69.5±5.5), we examined the relationship between amyloid levels (from PET imaging), neurite density (derived from diffusion MRI-based Neurite Orientation Dispersion and Density Imaging, NODDI), and global cognition (MoCA scores). NODDI is a biophysical diffusion MRI model that quantifies microstructural features of brain tissue through metrics like neurite density index (NDI) that may sensitively capture early neurodegenerative changes leading up to Alzheimer's Disease (AD). Spearman correlation analyses showed significant negative associations between amyloid and NDI in the right entorhinal cortex (ρ = -0.29; p = 0.02) and left fusiform gyrus (ρ = -0.26; p = 0.04). Amyloid also correlated with ODI in the left (ρ = -0.31; p = 0.011) and right fusiform gyrus (ρ = -0.33; p = 0.006). Mediation analyses revealed significant effects for NDI in the left entorhinal cortex (p = 0.02) and left fusiform gyrus (p = 0.006), and for ODI in the left fusiform gyrus (p = 0.044). These findings indicate that even in the absence of clinical symptoms, amyloid deposition may contribute to microstructural degradation in key brain areas, which in turn relates to cognitive function. NDI specifically may hold promise as an early imaging marker for identifying individuals at risk and tracking AD progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.